Pharmafile Logo
Pharmafocus logo
Advanced Search

Bexsero

Showing 9 posts of 9 posts found.

shutterstock_274590824

GSK launches patent infringement action against Pfizer

November 7, 2016
Sales and Marketing Bexsero, trumenba

GlaxoSmithKline has filed a patent infringement lawsuit against rival Pfizer over the alleged copying of its popular meningococcal group B …

News
GSK image

GSK and UK government agree meningitis B vaccine deal

March 30, 2015
Sales and Marketing AstraZeneca, Bexsero, GSK, Novartis, meningitis v, vaccines

The UK government has agreed a deal with GlaxoSmithKline to provide its meningitis B vaccine Bexsero on the NHS, after …

News
Novartis image

Novartis earns EMA and FDA nods for Jakavi and Bexsero

January 26, 2015
Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib

Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …

News

Bexsero and Sirturo clear winners at UK Prix Galien Awards

October 2, 2014
Medical Communications, Research and Development, Sales and Marketing 2014, Bexsero, Janssen, Novartis, awards, prix galien, sirturo

The first TB medication to be approved in four decades and the first ever vaccine to treat invasive meningococcal disease …

News
Novartis HQ

Novartis must drop vaccine price, says UK govt

August 5, 2014
Medical Communications, Sales and Marketing Bexsero, Novartis, innoculation, meningococcal vaccine

Novartis will have to significantly lower the price of its meningococcal B vaccine if it wants a lucrative UK inoculation …

News

UK rejects meningitis B vaccine Bexsero

July 25, 2013
Sales and Marketing Bexsero, Novartis, Vaccine, meningitis b

The UK government’s department for vaccinations has stunned observers by failing to back the world’s only vaccine for meningitis B. …

News

Novartis’ 2012 results flat

January 24, 2013
Sales and Marketing Bexsero, Jakavi, Novartis, generics, results

Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …

News
novartis image

EU approval for meningitis vaccine

January 23, 2013
Sales and Marketing Bexsero, CHMP, Novartis, meningitis

European regulators have approved Novartis’ Bexsero, making it the first broad coverage vaccine to target the leading cause of meningitis. …

News

Novartis submits meningococcal vaccine Bexsero for European approval

December 23, 2010
Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine

Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026